1. Home
  2. PLUG vs BEAM Comparison

PLUG vs BEAM Comparison

Compare PLUG & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUG
  • BEAM
  • Stock Information
  • Founded
  • PLUG 1997
  • BEAM 2017
  • Country
  • PLUG United States
  • BEAM United States
  • Employees
  • PLUG N/A
  • BEAM N/A
  • Industry
  • PLUG Industrial Machinery/Components
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PLUG Energy
  • BEAM Health Care
  • Exchange
  • PLUG Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • PLUG 1.8B
  • BEAM 1.9B
  • IPO Year
  • PLUG 1999
  • BEAM 2020
  • Fundamental
  • Price
  • PLUG $1.83
  • BEAM $29.53
  • Analyst Decision
  • PLUG Hold
  • BEAM Buy
  • Analyst Count
  • PLUG 26
  • BEAM 11
  • Target Price
  • PLUG $4.99
  • BEAM $45.90
  • AVG Volume (30 Days)
  • PLUG 54.5M
  • BEAM 1.2M
  • Earning Date
  • PLUG 11-12-2024
  • BEAM 11-05-2024
  • Dividend Yield
  • PLUG N/A
  • BEAM N/A
  • EPS Growth
  • PLUG N/A
  • BEAM N/A
  • EPS
  • PLUG N/A
  • BEAM N/A
  • Revenue
  • PLUG $684,486,000.00
  • BEAM $349,643,000.00
  • Revenue This Year
  • PLUG N/A
  • BEAM N/A
  • Revenue Next Year
  • PLUG $43.83
  • BEAM $6.04
  • P/E Ratio
  • PLUG N/A
  • BEAM N/A
  • Revenue Growth
  • PLUG N/A
  • BEAM 328.73
  • 52 Week Low
  • PLUG $1.60
  • BEAM $18.85
  • 52 Week High
  • PLUG $5.14
  • BEAM $49.50
  • Technical
  • Relative Strength Index (RSI)
  • PLUG 41.90
  • BEAM 71.55
  • Support Level
  • PLUG $1.88
  • BEAM $21.46
  • Resistance Level
  • PLUG $2.08
  • BEAM $32.29
  • Average True Range (ATR)
  • PLUG 0.18
  • BEAM 1.64
  • MACD
  • PLUG -0.03
  • BEAM 0.88
  • Stochastic Oscillator
  • PLUG 1.27
  • BEAM 81.22

About PLUG Plug Power Inc.

Plug Power is building an end-to-end green hydrogen ecosystem-from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

Share on Social Networks: